Zeke Capital Advisors »

Crispr Therapeutics shares owned by Zeke Capital Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Zeke Capital Advisors from 13F filings

Historical chart of Zeke Capital Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Zeke Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Zeke Capital Advisors

Quarter filed Position value Share count Share price at filing
2022-12-31 $1.3M 31k 40.65
2022-09-30 $2.3M 35k 65.34
2022-06-30 $2.1M 35k 60.75
2022-03-31 $1.9M 30k 62.69
2021-12-31 $1.8M 24k 75.79
2021-09-30 $1.5M 13k 111.97
2021-06-30 $2.2M 14k 161.92